Taking Control of Your Fuzzy

Similar documents
Key Activities. Ofer Reizes, Ph.D. Skills Development Director

Aligning internal teams to secure buy-in from external stakeholders: a critical part of launch strategy

Who We Are / Services

WRITING A SUCCESSFUL SBIR / STTR COMMERCIALIZATION PLAN. Ed Kase Business Development Consultant

Perspective: New European IVD Regulations New Concepts for Market Authorizations and Product Launch Schedules

Identifying Critical Factors Pre-launch

PPM Software Deployment Guide:

Procurement and Supplier engagement in New Product Development. Driving OMX early in the development cycle

When the Business Wants Waterfall Implementing Agile in a Phase-Based Environment

R&D Portfolio Planning In- and Out-licensing of Medicines

A High-Touch Approach to Improving Patient Access. Using field support to navigate reimbursement challenges

Best Practices for. new product development

Improving Acquisition in Government Requirements Management Leading Practices: CMMI-ACQ Visualization

PharmaPerspectiveonCDx. DrGillian Ellison

Start With the End in Mind A Diagnostic Company s Perspective on Companion Diagnostic Development. Paul Docherty PhD Relationship Management

FINDING THE MONEY: Turning Transactions Compliance into Cash. March John Thompson, Director Tom Grove, Vice President. 1 healthcare IT solutions

Project Management. Objectives 3/17/2015. David Borrill, MT, MBA, PMP

Adapting and Using VIRAL: Figuring out company maturity level and appropriate amount and use of MTI investment

Insights into the Evolving Pricing & Market Access Environment

As ONE for our Customers. DHL Express Romania March 2015

Alternate Title: How to survive in a world of constantly shrinking budgets

T H E B O T T O M L I N E

Amgen Supply Chain Segmentation The Journey to October 23, 2014

PAREXEL PARTNER PROGRAM. Broaden your reach with a partner you can trust

CHKD Nets $22M in CFO-Validated Savings with a Blend of CBA s 100-Day Workouts and High Impact Margin Improvements

Maturity Model Workstream

DEFINITIONS AND KEY MEASURES

How can regulatory affairs drive greater value for the patient and for the business?

Service Supply Chain Survey 2018 April 26, 2018

Developing and Delivering a Winning Investor Presentation

Lean Six Sigma Approach to New Product Development

QM strategic initiatives undertaken by Suzlon

An Industry Perspective

STRATEGIC GROWTH AND INNOVATION

Service Performance Insight

Selecting Software Development Life Cycles. Adapted from Chapter 4, Futrell

Optum Intelligent EDI. Achieve higher first-pass payment rates and help your organization get paid quickly and accurately.

EXPERT ISE YOU CAN TRUST

White paper. Reduce the Risks When Deploying Data Collection Technologies: Outsource Implemenation Services

Aerospace Advanced Product Quality Planning (Aerospace APQP) Introduction. Date: April Section 7.2

Process Mining The Next Big Thing

Paving the way to FDA? tips and pitfalls. The Nextar start up support program Dr. Orna Dreazen- CEO

Request for Proposals Facilitating Utility Smart Energy Education (FUSED)

Rapid Path to Recruiting

2013 Global Smart Card Personalization Solutions New Product Innovation Leadership Award

Strategic Outsourcing for Success

Portfolio Marketing. Research and Advisory Service

Welcome. Thank you for joining us. Irina Moissiu, Director Client Relations Laurie Furiness, EVP Operations & Consulting Services

Better, Cheaper, Faster A new EPR deployment strategy

Benchmarking the Pharma Industry s HEOR Functions

The Top Three Reasons Supply Chain Transformations Fail

Optimize New Product Development. Presenter s Name Presenter s Title

Delivering GxP compliant mobile applications a practical case study. Presented by: Mark Stevens

RELIEVING THE PAIN OF ANOC & EOC STREAMLINING DOCUMENT CREATION AND REDUCING COSTS WITH INTELLIGENT DYNAMIC PUBLISHING TECHNOLOGY

Ten Things You Must Do to Win. Presented by David Bol

Daitan White Paper The Software Development versus Maintenance Dilemma COMMON MISCALCULATIONS IMPACT REVENUE AND MARKET SHARE

Why Innovation Always Trumps Invention

Cloud Transformation Program Cloud Change Champions March

2017 Global Pharmaceutical Scientific Process and Technology Outsourcing Customer Service Leadership Award

Strategic delivery: Setting standards Increasing and informing choice. Details: Output: Demonstrating efficiency economy and value. Authority.

UK STEWARDSHIP CODE RESPONSE BY GENERATION INVESTMENT MANAGEMENT LLP OCTOBER 2016

Focused pharma engineering

LAUNCH MANAGEMENT. Preparing for a Global Launch. Through Alignment, Communication, Collaboration and Transparency

Procurement s contribution to major project delivery Robert Pease, The Faculty. CIPSA Major Projects Forum, 1 June 2011

Certified Identity Governance Expert (CIGE) Overview & Curriculum

Concurrent Session: Leadership and Execution Building the SOW Business Case

NEW PRODUCT DEVELOPMENT (NPD) PROCESS AN EXAMPLE OF INDUSTRIAL SECTOR

Complex Care Program Development: A New Framework for Design and Evaluation

Azure Infrastructure for SAP

MCRA Clinical More Than Your Average CRO. Clinical Project Management. Site Management and Study Monitoring. Data Management. Auxiliary Services

IT departments need to be the leader of technological. Business / Clinical leadership need to own enterprise solutions

Challenges and Opportunities in Pharma: Perspective for an Emerging Middle East April 24th, 2015

Implementation of an Electronic Health Record

Sales & Marketing. Walter Owens Executive Vice President Chief Sales & Marketing Officer

Current Trends at FDA: Implications for Data Requirements

Testing: The Critical Success Factor in the Transition to ICD-10

RESCUING A TROUBLED PROJECT

The Quality System Regulation

Tools To use with the Learning Plan Methodology. Business Implications of Emerging Technologies

Perspective: Convergence of CLIA and FDA Requirements A Rational Shift in the Regulatory Paradigm

Taking the Lead in Revenue Cycle Transformation

Project Prioritization as a Key Element in IT Strategic Demand Management

SAP NetWeaver Service Select for Master Data Management. Tuesday October 26 th 2004

Customizable VAD Power & Control Technology

W207: How should you leverage internal audit? October 26, 2016

Achieving Performance Excellence

Managing innovation. Philips Industry Consulting

The PLM for Small to Medium-Size Manufacturers Benchmark Report. Enabling Profitable Growth for SMEs

RWE from pre-clinical to launch. RWE from pre-clinical to launch. Standard of care Unmet needs. Disease burden Budget impact.

Hospital Radiology Management Overview

An Intellectual Asset Management Program For SMEs

IMBEDDING THE VOICE OF THE CUSTOMER IN NEW PRODUCT DEVELOPMENT. Hal Carper Tyson Foods June 21, 2006

CMMI-DEV V1.3 CMMI for Development Version 1.3 Quick Reference Guide

ME102 INVENTIVE DESIGN

3. Strategic Improvement Initiatives Diagnose key improvement areas and put the right focus, resources and plans in place to drive improvement.

See the world. differently. Embrace change and profit from marketplace uncertainty

Evaluation of the Prime Partnership between Accelence and Quintiles. James Brook Senior Director, Head Site Management Western Europe, Quintiles

The Four Disciplines of Executing Transformation Strategies in Healthcare

Price and Value Proposition

Salesforce Governance: A New Hope

Transcription:

Taking Control of Your Fuzzy Front End MassMedic Presentation September 22, 2010 Sanjeev Wadhwani Project Management Consultant Integrated Project Management Company, Inc.

Sanjeev Wadhwani Project Manager Integrated Project Management Company, Inc. One Broadway, 14 th floor Cambridge, MA 02142 Phone: (617) 401-2325 E-mail: swadhwani@ipmcinc.com

Agenda Measuring Success IPM Case Study Discussion

What Defines a Successful Product Launch? Better than 3x VC ROI Faster Time to Market Meets Users Needs Compliant Process Successful Launch Increases Market Share % Improves Patients Lives Reduces Healthcare Costs No product recalls

Successful Launch Main efforts spent on ensuring a successful device product launch Product Development Timeline Idea Launch Whether a device launch is successful is determined much earlier in the product development timeline

Top Six Reasons for Product Failure Unclear or continually changing product definitions Product does not meet customer or market requirements Unrealistic schedule expectations Projects not adequately staffed Unclear or continually changing priorities Unrealistic financial expectations 0% 10% 20% 30% 40% 50% Aberdeen Group, August 2006

Main Sources for New Product Ideas Customers 88% R&D 77% Marketing 75% Sales Other employees 43% 52% 0% 20% 40% 60% 80% 100% Best Practices, LLC

Uncovered Timing of Activities Balance of Activities

IPM CASE STUDY

Transforming Global Product Development Background Fortune 500 Medical Device / Diagnostic Company R&D Centers and outsourced Operations in US and EU Quality, Sales / Marketing, Regulatory primarily US based Portfolio of Class II and III Devices The Issue Products delayed to market Products did not meet all of the user needs Strong need to increase R&D throughput The Objective Get more products to market faster which meet the requirements of the end user.

Initial Assessment Lack of Portfolio Governance Products delayed to market Products did not meet all of the user needs Strong need to increase R&D throughput Over utilized R&D group Development time for IVD s >>> industry averages Lack of disciplinedapproach to product development Passive Voice of Customer (VOC) feedback process Development effort >>> market research effort Significant # of products in development

Current Product Development Process A D E B C F G H I Development / Design Transfer Product Launch Idea Lack of Portfolio Governance Over utilized R&D group Development time for IVD s >>> industry averages Lack of disciplinedapproach to product development Passive Voice of Customer (VOC) feedback process Development effort >>> market research effort Lack of control in critical upfront processes Product

Welcome the Fuzzy Front End Key activities between Idea Generation and Formal Development Fuzzy Front End Formal Development (i.e. Design Control) Development / Design Transfer Idea Provides key information to facilitate Go / No-Go decisions (1) 1 Cooper R.G., Edgett, S.J.(2008), Maximizing productivity in product innovation, in: Research Technology Management, March 1, 2008

Consider / Re-consider the Fuzzy Front End Products can fail due to technical hurdles, but most likely due to lack of true market New products have very high failure rates Myth Moving Ideas straight into Development reduces time to market Reality Average durations for Development can be much longer due to Verification and Validation (Formal Development) being an experimental exercise Products are launched into non-existent markets or not meeting all of the user needs

Step 1

Idea Screening Idea B Idea C Idea A Management Go / No-go Approval

Market Opportunity Assessment What is the application or concept? What is the high-level value proposition? Who are the main competitors? What initial markets are we targeting?

Freedom to Operate (FTO) Landscape Map of the "Starbucks Coffee Sleeve" Patent

Freedom to Operate (FTO) High-level patent landscape (lifecycle document) Determine best mix of outside (IP expertise) / inside (product insights) counsel Build a proactive, participatory relationship throughout the lifecycle

Regulatory Assessment High-Level Regulatory Assessment Preliminary regions forecasted to understand regulatory pathways and hurdles Closely tied with FTO and Market Opportunity Assessment Build a proactive, participatory relationship throughout the lifecycle

Portfolio Assessment B A F Portfolio mix Risk H D I C G E R&D throughput Development priority Return

Initial Wins Development / Design Transfer Product Launch Idea A D E F G H I B C OneCustomer Data Point Skunkworks Project Risk >>> Return Market landscape had significantly changed since inception

Concept Stage (Idea Screening) Idea B Idea C Idea A Market Research What is the Application or Concept? What is the Value Proposition? Is there a clear market needs? Strategy Business Alignment High-Level Regulatory Assessment Preliminary Freedom to Operate (FTO) Assessment Portfolio priority Technology High-Level Technological Assessment Management Go / No-Go Approval

Concept Stage Results Concept Fuzzy Front End Development / Design Transfer Product Launch Provide focusto the organization resulting in the best chance of success in getting the right ideasinto development and commercialization.

Formal Development (V&V) Move into Formal Development? NO! Commercial What exactlyare we making? Technical Design Control Proof of Concept

A Delicate Balance Commercial Technical Concept

Market Research Differentiation Factors Variables Importance Rating* (Out of 100%) Benchmark Performance Safety Major Complication Rates 40% Effectiveness Device Success Rate Procedural Success Rates 25% Ease of Use Deployment Time 15% Product X Patient Comfort Pain Level Patient Request 15% Price ASP Target 5%

Reimbursement Strategy a thorough reimbursement strategy has become as important as the FDA strategy in the success of a new device. Only 26% of the companies indicated that reimbursement was part of the formal product lifecycle development process Challenges to Buy-in on Reimbursement Issues Lake of awareness of potential consequences of reimbursement barriers 50% Inadequate authority of the reimbursement function 26% Inadequate support from senior executives 16% Inadequate support from CEO 8% How Medical Device Companies Deploy Reimbursement Resources, Report on the Compliance-Alliance Reimbursement Benchmarking Survey, Compliance- Alliance, LLC 2007

Reimbursement Strategy Payment Payment processes and amounts Coverage Determines eligibility for payment for products & services Coding Classifies patient conditions, services and supplies required Idea Reimbursement Research & Strategy Product Development Timeline Clinical Studies Focus on demonstration of enhanced outcomes and cost effectiveness Launch

Reimbursement Strategy The Global Impact

Proof of Concept Product Concept A Product Product Concept Concept B C Select Partners Prototype Testing Concept Selection Product Concept A Device Attributes Clinical Study Assessment Market Research / VOC

Feasibility Stage Product Concept A Market Research Technology Strategy Requirements Detailed Market Assessments Key Opinion Leaders Medical / Scientific Boards Initial Reimbursement Data Health Economics Prototype Development and evaluation Initial Manufacturing Assessments Clinical Strategy Pre-Submission Meetings Supplier Assessments Continued FTO Evaluation Publication Strategy Product Requirements (Design Inputs)

Feasibility Stage Results Concept Feasibility Development / Design Transfer Product Launch Fuzzy Front End Solidify the business case of the idea by capturing more robust product requirements and intended uses through detailed market research and proof of concept evaluations.

Formal Development (V&V) Move into Formal Development? NO! What we are building does not guranteehow we are building it

Planning What Design and Development Plan Deliverables Matrix by Stage Design History File Who Roles and Responsibility Matrix Decision Rights When Detailed project schedule Critical path assessment Acceleration opportunities How Much Detailed Budget Assessment Any Risks? Risk Management Process Feedback VOC IP Regulatory Stage Gate Reviews Design Reviews

Planning Stage Results Concept Feasibility Planning Development / Design Transfer Product Launch Fuzzy Front End Prior to entering formal development, ensure adequate preparation has been completed to increase the chances of developing and launching a successful product.

Refined Product Development Stage Gate Process Formal Development Begins Concept Feasibility Planning Development (V&V) Design Transfer Product Launch Fuzzy Front End The fuzzy front end can consume up to 50% of development time and it is where the course for the entire project and final end product are set Stage Gates Design Review Source: Chapter 3 Smith, Preston G. and Reinertsen, Donald G. (1998) Developing Products in Half the Time, 2nd Edition, John Wiley and Sons, New York, 1998

Formal Development (V&V) Move into Formal Development? YES!

Client Impact Client was not VC funded; however, was viewed as a stronger partner in Dx / Rx relationship Better than 3x VC ROI Faster Time to Market Meets Users Needs Compliant Process Successful Launch Increases Market Share % Improves Patient s Lives Reduces Healthcare Costs No product recalls / complaints None identified

Key Takeaways $$$$ and TTM are just a few factors determining product launch success Investigate Educate

Sanjeev Wadhwani Project Manager Integrated Project Management Company, Inc. One Broadway, 14 th floor Cambridge, MA 02142 Phone: (617) 401-2325 E-mail: swadhwani@ipmcinc.com